296 related articles for article (PubMed ID: 32933189)
1. Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Nagahashi M; Takabe K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933189
[TBL] [Abstract][Full Text] [Related]
2. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
J Immunol Res; 2020; 2020():5618786. PubMed ID: 33457427
[TBL] [Abstract][Full Text] [Related]
3. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.
Kim EY; Choi B; Kim JE; Park SO; Kim SM; Chang EJ
Cells; 2020 Jan; 9(1):. PubMed ID: 31935914
[TBL] [Abstract][Full Text] [Related]
5. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
[TBL] [Abstract][Full Text] [Related]
6. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.
Wu R; Gandhi S; Tokumaru Y; Asaoka M; Oshi M; Yan L; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2022 Aug; 195(1):17-31. PubMed ID: 35793004
[TBL] [Abstract][Full Text] [Related]
8. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
Liu D; Vadgama J; Wu Y
Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
[TBL] [Abstract][Full Text] [Related]
9. Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor.
Takeshita T; Yan L; Asaoka M; Rashid O; Takabe K
Sci Rep; 2019 Nov; 9(1):16942. PubMed ID: 31729458
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Huang JL; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Takabe K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796516
[TBL] [Abstract][Full Text] [Related]
11. Altered Leukocyte Sphingolipid Pathway in Breast Cancer.
Maia LP; Santos PS; Alves PT; Rodrigues CM; Araújo TG; Maia YCP; Câmara ATF; Santos DW; Goulart LR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186783
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate (S1P) produced by sphingosine kinase 1 (SphK1) and exported via ABCC1 is related to hepatocellular carcinoma (HCC) progression.
Satyananda V; Oshi M; Tokumaru Y; Maiti A; Hait N; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2021; 11(9):4394-4407. PubMed ID: 34659894
[TBL] [Abstract][Full Text] [Related]
13. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Ueno T; Toi M; Saji H; Muta M; Bando H; Kuroi K; Koike M; Inadera H; Matsushima K
Clin Cancer Res; 2000 Aug; 6(8):3282-9. PubMed ID: 10955814
[TBL] [Abstract][Full Text] [Related]
14. Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome.
Sekiguchi M; Iwasaki T; Kitano M; Kuno H; Hashimoto N; Kawahito Y; Azuma M; Hla T; Sano H
J Immunol; 2008 Feb; 180(3):1921-8. PubMed ID: 18209090
[TBL] [Abstract][Full Text] [Related]
15. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Assessment of Leukocyte Involvement in Angiogenesis.
Ahmad NS; Martin SG; Storr SJ
Methods Mol Biol; 2016; 1430():49-57. PubMed ID: 27172945
[TBL] [Abstract][Full Text] [Related]
17. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
[TBL] [Abstract][Full Text] [Related]
19. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
20. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K
Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
